|
Exchange Received Time  02/08/2017 14:52:48 Exchange Disseminated Time 02/08/2017 14:52:51 Time Taken 00:00:03 | JPL/SEC/RESU-NOT1/ Date : August 2nd, 2017 To, The National Stock Exchange of India Ltd. Exchange Plaza, Bandara-Kurla Complex Bandra (E), Mumbai - 400 051. Ph. 022-26598452 To, The Bombay Stock Exchange Limited Pherozebhoy Jeejeebhoy Tower Dalal Street, Mumbai - 400 001 Ph. 022-22721234 SUBJECT : NOTICE FOR BOARD MEETING TO CONSIDER UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.06.2017 Dear Sir, Pursuant to Regulation 29 read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company will be held on Monday, the 14th day of August, 2017. Inter - alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended 30th June, 2017. This Notice is also available on the website of the Company , www.jagsonpal .com and also on the website of the Bombay Stock Exchange (BSE Ltd.) www.bseindia.com .and National Stock Exchange of India (NSE) www.nseindia.com. Thanking you. Yours faithfully, for JAGSONPAL PHARMACEUTICALS LIMITED R K KAPOOR COMPLIANCE OFFICER CUM COMPANY SECRETARY JPL/SEC/LODR-Comp/reS-Not1 Date : August 2nd, 2017 To, The National Stock Exchange of India Ltd. Exchange Plaza, Bandara-Kurla Complex Bandra (E), Mumbai - 400 051. Ph. 022-26598452 To, The Bombay Stock Exchange Limited Pherozebhoy Jeejeebhoy Tower Dalal Street, Mumbai - 400 001 Ph. 022-22721234 SUBJECT : Closure of Trading Window Dear Sir, Jagsonpal Pharmaceuticals Limited informs BSE & NSE that Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for dealing in the securities of the Company for all the persons defined under the said Regulations including Director/Officer and Employees of the Company from August 2nd, 2017 till 48hrs from the date of declaration of the Un-audited Financial Results for the year ended 30th June, 2017. Thanking you. Yours faithfully, for JAGSONPAL PHARMACEUTICALS LIMITED R K KAPOOR COMPLIANCE OFFICER CUM COMPANY SECRETARY |
|
|